.jpg)
Apogenix develops innovative protein therapeutics for the treatment of cancer and other malignant diseases. Our lead drug candidate APG101 has demonstrated a statistically significant efficacy in a controlled phase II trial in recurrent glioblastoma.
Top Board Management Software Awards 2021
Regulatory chromatin rewiring promotes metabolic switching during adaptation to oncogenic receptor tyrosine kinase inhibition
TNF/TNFR Superfamily ǀ Apogenix
Apogee DA-16-X
Metadata Management Tool- Metadata Automation Platform-ApoGI
Clinical Candidates ǀ Apogenix
Volunteer Board Management Software - BoardSpace
Control Board Amlogic-C76 for S19XP/S19j Pro+ - BITMARS
Office Space Gypsum Board
Pingboard on X: 's entire executive org chart as they plan for the new year. Thanks to @eugenekim222 at @CNBCtech for the article: Click here to view > Build your own
HERA Technology Platform ǀ Apogenix
Apogee Products - Visionca
Control Board Amlogic-C76 for S19XP/S19j Pro+ - BITMARS
Gene expression profiles in genome instability-based classes of colorectal cancer, BMC Cancer
